Frankie Leigh Shelton: Clinical Researcher at UVA Health & Health Strategist
In this episode, Nora welcomes Frankie Leigh Shelton, a two time founder and clinical researcher who operates at the vital intersection of healthcare innovation and systems adoption. With a background as a clinical nutritionist and a Master of Health Administration, Frankie dedicated over a decade to the digestive and cardiometabolic complexities of women’s health. Her work, including Fulbright funded research on the clinical adoption of wearable and hormonal data, focuses on a critical question: how do we move beyond consumer gadgets to create data that clinicians actually trust and use to save lives?
The conversation highlights Frankie’s current role advancing the women’s cardiology research portfolio at the University of Virginia. Nora and Frankie discuss the systemic gaps in women’s heart health, specifically how hormonal shifts during perimenopause are often misclassified as mere "symptoms" rather than significant cardiovascular risk factors. They dive into the reality of building research backed ventures and the friction between scientific evidence and clinical adoption. Frankie also shares her insights as a New Ventures Program Lead for WELL, helping digital health founders translate promising ideas into early traction and evidence-based models.
This episode is for leaders and founders in the health tech space who want to understand the mechanics of bridging the gap between academic research and mainstream medical practice.
Key Topics:
How observing gaps in patient care led to a career focused on improving research frameworks for women.
Understanding how declining estrogen levels impact cholesterol and glucose, and why this is a critical window for cardiovascular intervention.
Why some medical breakthroughs succeed in the lab but fail to integrate into the daily workflow of a hospital or clinic.
A look at UVA’s work with microvascular disease and imaging procedures designed specifically for the female heart.
What is required for clinicians to integrate continuous glucose monitors and hormonal tracking into preventive care models.
The common challenges of navigating reimbursement models and clinical validation in a crowded market.
How to determine when a strong research question actually translates into a scalable business opportunity.
